Cost-effectiveness of IMI/CIL/REL for the treatment of carbapenem non-susceptible Gram-negative bacterial infections

Cost-effectiveness of IMI/CIL/REL for the treatment of carbapenem non-susceptible Gram-negative bacterial infections

Objective: The objective of this analysis was to evaluate the cost-effectiveness of imipenem/cilastatin/relebactam compared to colistin-imipenem in the treatment of hospitalized patients with Gram-negative bacterial infections caused by imipenem-resistant pathogens. The perspective was both that of...

Full description

Bibliographic Details
Main Authors:	Martina Paoletti, Andrea Marcellusi, Joe Yang, Francesco Saverio Mennini
Format:	Article
Language:	English
Published:	AboutScience Srl 2023-04-01
Series:	Global & Regional Health Technology Assessment
Subjects:	Cost-effectiveness Economic evaluation Gram-negative bacterial infection
Online Access:	https://journals.aboutscience.eu/index.php/grhta/article/view/2488

Similar Items

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Chinese Children
by: Xuedong Jia, et al.
Published: (2022-05-01)

Network meta-analysis of antibiotic resistance patterns in gram-negative bacterial infections: a comparative study of carbapenems, fluoroquinolones, and aminoglycosides
by: Ghazala Muteeb
Published: (2023-11-01)

In vitro activity of cefiderocol against Gram-negative bacterial pathogens in Germany
by: Philipp Thelen, et al.
Published: (2022-03-01)

Carbapenem-Resistant Gram-Negative Bacterial Infections at a Tertiary Health Care Center in Nepal: An Observational Study
by: Dimpi Konwar, et al.
Published: (2024-12-01)

Difference of Procalcitonin Levels in Gram-Positive and Gram-Negative Bacterial Sepsis Patients of Indonesia Army Central Hospital Gatot Soebroto in 2016
by: Nindy Handayani, et al.
Published: (2022-01-01)

Emergence of Carbapenem-Resistant Gram-Negative Isolates in Hospital Settings in Djibouti
by: Ayan Ali Ragueh, et al.
Published: (2023-06-01)

Direct antimicrobial susceptibility testing of Gram-negative bacteria from positive blood cultures
by: Andrea Zappavigna, et al.
Published: (2014-03-01)

Synergistic Activity and Mechanism of Sanguinarine with Polymyxin B against Gram-Negative Bacterial Infections
by: Luyao Qiao, et al.
Published: (2024-01-01)

Carbapenem-Resistant Gram-Negative Fermenting and Non-Fermenting Rods Isolated from Hospital Patients in Poland—What Are They Susceptible to?
by: Małgorzata Brauncajs, et al.
Published: (2022-11-01)

Development and validation of a nomogram for predicting gram-negative bacterial infections in patients with peritoneal dialysis-associated peritonitis
by: Guiling Liu, et al.
Published: (2023-08-01)

Machine learning model for the prediction of gram-positive and gram-negative bacterial bloodstream infection based on routine laboratory parameters
by: Fan Zhang, et al.
Published: (2023-10-01)

Molecular epidemiology of carbapenem-resistant gram-negative bacilli in Ecuador
by: Claudia Soria-Segarra, et al.
Published: (2024-04-01)

Cysteine Potentiates Bactericidal Antibiotics Activity Against Gram-Negative Bacterial Persisters
by: Liu Y, et al.
Published: (2020-07-01)

Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005–2010
by: Morfin-Otero Rayo, et al.
Published: (2012-06-01)

Antimicrobial susceptibility pattern of Gram-negative uropathogens at a tertiary care hospital in Gujarat
by: Mihirkumar K Oza, et al.
Published: (2024-06-01)

Gram-Negative Bacterial Envelope Homeostasis under Oxidative and Nitrosative Stress
by: Thibault Chautrand, et al.
Published: (2022-04-01)

Risk factors and mortality rates of carbapenem-resistant Gram-negative bacterial infections in intensive care units
by: Tulay Orhan Kuloglu, et al.
Published: (2024-07-01)

An update on carbapenem resistance in nonfermenting gram-negative bacteria
by: K V Sreejith, et al.
Published: (2023-01-01)

Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis
by: Shuhua Li, et al.
Published: (2016-01-01)

Assessment of the Susceptibility of Clinical Gram-Negative and Gram-Positive Bacterial Strains to Fosfomycin and Significance of This Antibiotic in Infection Treatment
by: Beata Kowalska-Krochmal, et al.
Published: (2022-11-01)

Resveratrol Reverts Tolerance and Restores Susceptibility to Chlorhexidine and Benzalkonium in Gram-Negative Bacteria, Gram-Positive Bacteria and Yeasts
by: Antonella Migliaccio, et al.
Published: (2022-07-01)

Clinical characteristics and antimicrobial therapy of healthcare-associated carbapenem-non-susceptible gram-negative bacterial meningitis: a 16-year retrospective cohort study
by: Jiyan Xu, et al.
Published: (2024-04-01)

In vitro activity of eravacycline and comparators against Gram-negative and Gram-positive bacterial isolates collected from patients globally between 2017 and 2020
by: Stephen Hawser, et al.
Published: (2023-06-01)

Cross-Sectional Assessment on Carbapenem-Resistant Gram-Negative Bacteria Isolated from Patients in Moldova
by: Vadim Nirca, et al.
Published: (2025-02-01)

Evaluation of Antimicrobial Susceptibility of Gram Negative Organisms by Minimum Inhibitory Concentration Method in Bandar Abbas, South of Iran
by: Mahin Jamshidi Makiani, et al.
Published: (2017-09-01)

Detection and molecular characterization of carbapenem-resistant gram-negative bacterial isolates
by: Aliaa A. Mustafa, et al.
Published: (2024-11-01)

Cost-effectiveness analysis of polymyxin B versus colistin for treating patients with carbapenem-resistant gram-negative bacterial infections
by: Ye Wang, et al.
Published: (2024-10-01)

Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens
by: Flora Cruz-López, et al.
Published: (2022-05-01)

Prolonged Infusions of Meropenem in Pediatric Infections with Carbapenem Resistant Gram Negative Bacteria
by: Sevgen Tanır Basaranoglu, et al.
Published: (2024-12-01)

Efficacy and mortality of ceftazidime/avibactam-based regimens in carbapenem-resistant Gram-negative bacteria infections: A retrospective multicenter observational study
by: Hai-Hui Zhuang, et al.
Published: (2023-06-01)

Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon
by: Mariam Rima, et al.
Published: (2022-09-01)

Metabolic requirements of CD160 expressing memory‐like NK cells in Gram‐negative bacterial infection
by: Anucha Preechanukul, et al.
Published: (2024-01-01)

Evaluation of post-antibiotic effect in Gram-negative and Gram-positive bacteria
by: Elisa Tavella, et al.
Published: (2008-03-01)

Differential Gene Sets Profiling in Gram-Negative and Gram-Positive Sepsis
by: Qingliang Wang, et al.
Published: (2022-02-01)

SURVEILLANCE OF CARBAPENEM-RESISTANT GRAM-NEGATIVE BACTERIA FROM ANIMAL SOURCES IN MATHURA REGION, UTTAR PRADESH, INDIA
by: A. Arun, et al.
Published: (2022-08-01)

Carbapenem-Resistant Gram-Negative Bacilli Characterization in a Tertiary Care Center from El Bajio, Mexico
by: Jose Raul Nieto-Saucedo, et al.
Published: (2023-08-01)

Comparison of Two Transmission Electron Microscopy Methods to Visualize Drug-Induced Alterations of Gram-Negative Bacterial Morphology
by: Hang Thi Nguyen, et al.
Published: (2021-03-01)

A Multicenter Retrospective Study on Real-World Outcomes of ceftazidime-avibactam in gram-negative bacterial infection in Taiwan
by: Tsung Ying Zegma Yang, et al.
Published: (2024-12-01)

A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) vs piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP)
by: Junjie Li, et al.
Published: (2025-04-01)

Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia
by: Ana Paula Schonardie, et al.
Published: (2023-03-01)